Bibliography
- Bolland MJ, Grey AB, Gamble GD, Effect of osteoporosis treatment on mortality: a meta-analysis. J Clin Endocrinol Metab 2010;95:1174-81
- Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science 2000;289:1508-14
- Rosen CJ. Clinical practice. Postmenopausal osteoporosis. N Engl J Med 2005;353:595-603
- Karsenty G. Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab 2006;4:341-8
- Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 2005;115(12):3318-25
- Roggia C, Gao Y, Cenci S, Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci USA 2001;98:13960-5
- Weitzmann MN, Pacifici R. Estrogen regulation of immune cell bone interactions. Ann NY Acad Sci 2006;1068:256-74
- Sun L, Peng Y, Sharrow AC, FSH directly regulates bone mass. Cell 2006;125(2):247-60
- Nakamura T, Imai Y, Matsumoto T, Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 2007;130:811-23
- Krum SA, Miranda-Carboni GA, Lupien M, Unique ERalpha cistromes control cell type-specific gene regulation. Mol Endocrinol 2008;22:2393-406
- Krum SA, Miranda-Carboni GA, Hauschka PV, Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival. Embo J 2008;27:535-45
- Barrett-Connor E, Mosca L, Collins P, Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med 2006;355:125-37
- Favus MJ. Bisphosphonates for osteoporosis. N Engl J Med 2010;363:2027-35
- Kovacic N, Grcevic D, Katavic V, Targeting Fas in osteoresorptive disorders. Expert Opin Ther Targets 2010;14:1121-34
- Cummings SR, San Martin J, McClung MR, Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 2009;361:756-65
- Taylor PC, Feldmann M. Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis. Nat Rev Rheumatol 2009;5:578-82
- O'Brien DI, Nally K, Kelly RG, Targeting the Fas/Fas ligand pathway in cancer. Expert Opin Ther Targets 2005;9:1031-44
- Fujiki R, Chikanishi T, Hashiba W, GlcNAcylation of a histone methyltransferase in retinoic-acid-induced granulopoiesis. Nature 2009;459:455-9
- Takada I, Mihara M, Suzawa M, A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation. Nat Cell Biol 2007;9:1273-85
- Kitagawa H, Fujiki R, Yoshimura K, The chromatin-remodeling complex WINAC targets a nuclear receptor to promoters and is impaired in Williams syndrome. Cell 2003;113:905-17
- Kim MS, Kondo T, Takada I, DNA demethylation in hormone-induced transcriptional derepression. Nature 2009;461:1007–12